Pharma & Healthcare
Global Topical Recombinant Human Thrombin Market Research Report 2026
- Feb 03, 26
- ID: 699056
- Pages: 98
- Figures: 93
- Views: 6
This report delivers a comprehensive overview of the global Topical Recombinant Human Thrombin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Topical Recombinant Human Thrombin. The Topical Recombinant Human Thrombin market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Topical Recombinant Human Thrombin market comprehensively. Regional market sizes by Capacity, by Application, by Solvent, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Topical Recombinant Human Thrombin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Capacity, by Application, and by region.
Market Segmentation
By Company
Baxter
Suzhou Zelgen Biopharmaceuticals
Segment by Capacity
2000/Bottle
5000/Bottle
Others
Segment by Solvent
Lyophilized Powder
Ready to Use Solution
Segment by Use
Direct External Use
Carrier Composite External Use
by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Capacity, by Application, by Solvent, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Topical Recombinant Human Thrombin manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Topical Recombinant Human Thrombin sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Capacity, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Topical Recombinant Human Thrombin market comprehensively. Regional market sizes by Capacity, by Application, by Solvent, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Topical Recombinant Human Thrombin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Capacity, by Application, and by region.
Market Segmentation
By Company
Baxter
Suzhou Zelgen Biopharmaceuticals
Segment by Capacity
2000/Bottle
5000/Bottle
Others
Segment by Solvent
Lyophilized Powder
Ready to Use Solution
Segment by Use
Direct External Use
Carrier Composite External Use
by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Capacity, by Application, by Solvent, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Topical Recombinant Human Thrombin manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Topical Recombinant Human Thrombin sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Capacity, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Topical Recombinant Human Thrombin Market Overview
1.1 Product Definition
1.2 Topical Recombinant Human Thrombin by Capacity
1.2.1 Global Topical Recombinant Human Thrombin Market Value by Capacity: 2025 vs 2032
1.2.2 2000/Bottle
1.2.3 5000/Bottle
1.2.4 Others
1.3 Topical Recombinant Human Thrombin by Solvent
1.3.1 Global Topical Recombinant Human Thrombin Market Value by Solvent: 2025 vs 2032
1.3.2 Lyophilized Powder
1.3.3 Ready to Use Solution
1.4 Topical Recombinant Human Thrombin by Use
1.4.1 Global Topical Recombinant Human Thrombin Market Value by Use: 2025 vs 2032
1.4.2 Direct External Use
1.4.3 Carrier Composite External Use
1.5 Topical Recombinant Human Thrombin by Application
1.5.1 Global Topical Recombinant Human Thrombin Market Value by Application: 2025 vs 2032
1.5.2 Hospital
1.5.3 Clinic
1.6 Global Topical Recombinant Human Thrombin Market Size Estimates and Forecasts
1.6.1 Global Topical Recombinant Human Thrombin Revenue 2021–2032
1.6.2 Global Topical Recombinant Human Thrombin Sales 2021–2032
1.6.3 Global Topical Recombinant Human Thrombin Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Topical Recombinant Human Thrombin Market Competition by Manufacturers
2.1 Global Topical Recombinant Human Thrombin Sales Market Share by Manufacturers (2021–2026)
2.2 Global Topical Recombinant Human Thrombin Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Topical Recombinant Human Thrombin Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Topical Recombinant Human Thrombin, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Topical Recombinant Human Thrombin, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Topical Recombinant Human Thrombin, Product Types and Applications
2.7 Global Key Manufacturers of Topical Recombinant Human Thrombin, Date of Entry into the Industry
2.8 Global Topical Recombinant Human Thrombin Market Competitive Situation and Trends
2.8.1 Global Topical Recombinant Human Thrombin Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Topical Recombinant Human Thrombin Players Market Share by Revenue
2.8.3 Global Topical Recombinant Human Thrombin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Topical Recombinant Human Thrombin Market Scenario by Region
3.1 Global Topical Recombinant Human Thrombin Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Topical Recombinant Human Thrombin Sales by Region: 2021–2032
3.2.1 Global Topical Recombinant Human Thrombin Sales by Region: 2021–2026
3.2.2 Global Topical Recombinant Human Thrombin Sales by Region: 2027–2032
3.3 Global Topical Recombinant Human Thrombin Revenue by Region: 2021–2032
3.3.1 Global Topical Recombinant Human Thrombin Revenue by Region: 2021–2026
3.3.2 Global Topical Recombinant Human Thrombin Revenue by Region: 2027–2032
3.4 North America Topical Recombinant Human Thrombin Market Facts & Figures by Country
3.4.1 North America Topical Recombinant Human Thrombin Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Topical Recombinant Human Thrombin Sales by Country (2021–2032)
3.4.3 North America Topical Recombinant Human Thrombin Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Topical Recombinant Human Thrombin Market Facts & Figures by Country
3.5.1 Europe Topical Recombinant Human Thrombin Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Topical Recombinant Human Thrombin Sales by Country (2021–2032)
3.5.3 Europe Topical Recombinant Human Thrombin Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Topical Recombinant Human Thrombin Market Facts & Figures by Region
3.6.1 Asia Pacific Topical Recombinant Human Thrombin Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Topical Recombinant Human Thrombin Sales by Region (2021–2032)
3.6.3 Asia Pacific Topical Recombinant Human Thrombin Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Topical Recombinant Human Thrombin Market Facts & Figures by Country
3.7.1 Latin America Topical Recombinant Human Thrombin Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Topical Recombinant Human Thrombin Sales by Country (2021–2032)
3.7.3 Latin America Topical Recombinant Human Thrombin Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Topical Recombinant Human Thrombin Market Facts & Figures by Country
3.8.1 Middle East and Africa Topical Recombinant Human Thrombin Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Topical Recombinant Human Thrombin Sales by Country (2021–2032)
3.8.3 Middle East and Africa Topical Recombinant Human Thrombin Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Capacity
4.1 Global Topical Recombinant Human Thrombin Sales by Capacity (2021–2032)
4.1.1 Global Topical Recombinant Human Thrombin Sales by Capacity (2021–2026)
4.1.2 Global Topical Recombinant Human Thrombin Sales by Capacity (2027–2032)
4.1.3 Global Topical Recombinant Human Thrombin Sales Market Share by Capacity (2021–2032)
4.2 Global Topical Recombinant Human Thrombin Revenue by Capacity (2021–2032)
4.2.1 Global Topical Recombinant Human Thrombin Revenue by Capacity (2021–2026)
4.2.2 Global Topical Recombinant Human Thrombin Revenue by Capacity (2027–2032)
4.2.3 Global Topical Recombinant Human Thrombin Revenue Market Share by Capacity (2021–2032)
4.3 Global Topical Recombinant Human Thrombin Price by Capacity (2021–2032)
5 Segment by Application
5.1 Global Topical Recombinant Human Thrombin Sales by Application (2021–2032)
5.1.1 Global Topical Recombinant Human Thrombin Sales by Application (2021–2026)
5.1.2 Global Topical Recombinant Human Thrombin Sales by Application (2027–2032)
5.1.3 Global Topical Recombinant Human Thrombin Sales Market Share by Application (2021–2032)
5.2 Global Topical Recombinant Human Thrombin Revenue by Application (2021–2032)
5.2.1 Global Topical Recombinant Human Thrombin Revenue by Application (2021–2026)
5.2.2 Global Topical Recombinant Human Thrombin Revenue by Application (2027–2032)
5.2.3 Global Topical Recombinant Human Thrombin Revenue Market Share by Application (2021–2032)
5.3 Global Topical Recombinant Human Thrombin Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Topical Recombinant Human Thrombin Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Baxter Topical Recombinant Human Thrombin Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Suzhou Zelgen Biopharmaceuticals
6.2.1 Suzhou Zelgen Biopharmaceuticals Company Information
6.2.2 Suzhou Zelgen Biopharmaceuticals Description and Business Overview
6.2.3 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Product Portfolio
6.2.5 Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Topical Recombinant Human Thrombin Industry Chain Analysis
7.2 Topical Recombinant Human Thrombin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Topical Recombinant Human Thrombin Production Mode & Process Analysis
7.4 Topical Recombinant Human Thrombin Sales and Marketing
7.4.1 Topical Recombinant Human Thrombin Sales Channels
7.4.2 Topical Recombinant Human Thrombin Distributors
7.5 Topical Recombinant Human Thrombin Customer Analysis
8 Topical Recombinant Human Thrombin Market Dynamics
8.1 Topical Recombinant Human Thrombin Industry Trends
8.2 Topical Recombinant Human Thrombin Market Drivers
8.3 Topical Recombinant Human Thrombin Market Challenges
8.4 Topical Recombinant Human Thrombin Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Topical Recombinant Human Thrombin by Capacity
1.2.1 Global Topical Recombinant Human Thrombin Market Value by Capacity: 2025 vs 2032
1.2.2 2000/Bottle
1.2.3 5000/Bottle
1.2.4 Others
1.3 Topical Recombinant Human Thrombin by Solvent
1.3.1 Global Topical Recombinant Human Thrombin Market Value by Solvent: 2025 vs 2032
1.3.2 Lyophilized Powder
1.3.3 Ready to Use Solution
1.4 Topical Recombinant Human Thrombin by Use
1.4.1 Global Topical Recombinant Human Thrombin Market Value by Use: 2025 vs 2032
1.4.2 Direct External Use
1.4.3 Carrier Composite External Use
1.5 Topical Recombinant Human Thrombin by Application
1.5.1 Global Topical Recombinant Human Thrombin Market Value by Application: 2025 vs 2032
1.5.2 Hospital
1.5.3 Clinic
1.6 Global Topical Recombinant Human Thrombin Market Size Estimates and Forecasts
1.6.1 Global Topical Recombinant Human Thrombin Revenue 2021–2032
1.6.2 Global Topical Recombinant Human Thrombin Sales 2021–2032
1.6.3 Global Topical Recombinant Human Thrombin Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Topical Recombinant Human Thrombin Market Competition by Manufacturers
2.1 Global Topical Recombinant Human Thrombin Sales Market Share by Manufacturers (2021–2026)
2.2 Global Topical Recombinant Human Thrombin Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Topical Recombinant Human Thrombin Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Topical Recombinant Human Thrombin, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Topical Recombinant Human Thrombin, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Topical Recombinant Human Thrombin, Product Types and Applications
2.7 Global Key Manufacturers of Topical Recombinant Human Thrombin, Date of Entry into the Industry
2.8 Global Topical Recombinant Human Thrombin Market Competitive Situation and Trends
2.8.1 Global Topical Recombinant Human Thrombin Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Topical Recombinant Human Thrombin Players Market Share by Revenue
2.8.3 Global Topical Recombinant Human Thrombin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Topical Recombinant Human Thrombin Market Scenario by Region
3.1 Global Topical Recombinant Human Thrombin Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Topical Recombinant Human Thrombin Sales by Region: 2021–2032
3.2.1 Global Topical Recombinant Human Thrombin Sales by Region: 2021–2026
3.2.2 Global Topical Recombinant Human Thrombin Sales by Region: 2027–2032
3.3 Global Topical Recombinant Human Thrombin Revenue by Region: 2021–2032
3.3.1 Global Topical Recombinant Human Thrombin Revenue by Region: 2021–2026
3.3.2 Global Topical Recombinant Human Thrombin Revenue by Region: 2027–2032
3.4 North America Topical Recombinant Human Thrombin Market Facts & Figures by Country
3.4.1 North America Topical Recombinant Human Thrombin Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Topical Recombinant Human Thrombin Sales by Country (2021–2032)
3.4.3 North America Topical Recombinant Human Thrombin Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Topical Recombinant Human Thrombin Market Facts & Figures by Country
3.5.1 Europe Topical Recombinant Human Thrombin Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Topical Recombinant Human Thrombin Sales by Country (2021–2032)
3.5.3 Europe Topical Recombinant Human Thrombin Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Topical Recombinant Human Thrombin Market Facts & Figures by Region
3.6.1 Asia Pacific Topical Recombinant Human Thrombin Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Topical Recombinant Human Thrombin Sales by Region (2021–2032)
3.6.3 Asia Pacific Topical Recombinant Human Thrombin Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Topical Recombinant Human Thrombin Market Facts & Figures by Country
3.7.1 Latin America Topical Recombinant Human Thrombin Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Topical Recombinant Human Thrombin Sales by Country (2021–2032)
3.7.3 Latin America Topical Recombinant Human Thrombin Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Topical Recombinant Human Thrombin Market Facts & Figures by Country
3.8.1 Middle East and Africa Topical Recombinant Human Thrombin Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Topical Recombinant Human Thrombin Sales by Country (2021–2032)
3.8.3 Middle East and Africa Topical Recombinant Human Thrombin Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Capacity
4.1 Global Topical Recombinant Human Thrombin Sales by Capacity (2021–2032)
4.1.1 Global Topical Recombinant Human Thrombin Sales by Capacity (2021–2026)
4.1.2 Global Topical Recombinant Human Thrombin Sales by Capacity (2027–2032)
4.1.3 Global Topical Recombinant Human Thrombin Sales Market Share by Capacity (2021–2032)
4.2 Global Topical Recombinant Human Thrombin Revenue by Capacity (2021–2032)
4.2.1 Global Topical Recombinant Human Thrombin Revenue by Capacity (2021–2026)
4.2.2 Global Topical Recombinant Human Thrombin Revenue by Capacity (2027–2032)
4.2.3 Global Topical Recombinant Human Thrombin Revenue Market Share by Capacity (2021–2032)
4.3 Global Topical Recombinant Human Thrombin Price by Capacity (2021–2032)
5 Segment by Application
5.1 Global Topical Recombinant Human Thrombin Sales by Application (2021–2032)
5.1.1 Global Topical Recombinant Human Thrombin Sales by Application (2021–2026)
5.1.2 Global Topical Recombinant Human Thrombin Sales by Application (2027–2032)
5.1.3 Global Topical Recombinant Human Thrombin Sales Market Share by Application (2021–2032)
5.2 Global Topical Recombinant Human Thrombin Revenue by Application (2021–2032)
5.2.1 Global Topical Recombinant Human Thrombin Revenue by Application (2021–2026)
5.2.2 Global Topical Recombinant Human Thrombin Revenue by Application (2027–2032)
5.2.3 Global Topical Recombinant Human Thrombin Revenue Market Share by Application (2021–2032)
5.3 Global Topical Recombinant Human Thrombin Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Topical Recombinant Human Thrombin Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Baxter Topical Recombinant Human Thrombin Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Suzhou Zelgen Biopharmaceuticals
6.2.1 Suzhou Zelgen Biopharmaceuticals Company Information
6.2.2 Suzhou Zelgen Biopharmaceuticals Description and Business Overview
6.2.3 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Product Portfolio
6.2.5 Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Topical Recombinant Human Thrombin Industry Chain Analysis
7.2 Topical Recombinant Human Thrombin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Topical Recombinant Human Thrombin Production Mode & Process Analysis
7.4 Topical Recombinant Human Thrombin Sales and Marketing
7.4.1 Topical Recombinant Human Thrombin Sales Channels
7.4.2 Topical Recombinant Human Thrombin Distributors
7.5 Topical Recombinant Human Thrombin Customer Analysis
8 Topical Recombinant Human Thrombin Market Dynamics
8.1 Topical Recombinant Human Thrombin Industry Trends
8.2 Topical Recombinant Human Thrombin Market Drivers
8.3 Topical Recombinant Human Thrombin Market Challenges
8.4 Topical Recombinant Human Thrombin Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Topical Recombinant Human Thrombin Market Value by Capacity (US$ Million), 2025 vs 2032
Table 2. Global Topical Recombinant Human Thrombin Market Value by Solvent (US$ Million), 2025 vs 2032
Table 3. Global Topical Recombinant Human Thrombin Market Value by Use (US$ Million), 2025 vs 2032
Table 4. Global Topical Recombinant Human Thrombin Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Topical Recombinant Human Thrombin Market Competitive Situation by Manufacturers in 2025
Table 6. Global Topical Recombinant Human Thrombin Sales (K Units) of Key Manufacturers (2021–2026)
Table 7. Global Topical Recombinant Human Thrombin Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Topical Recombinant Human Thrombin Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Topical Recombinant Human Thrombin Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Topical Recombinant Human Thrombin Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Topical Recombinant Human Thrombin, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Topical Recombinant Human Thrombin, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Topical Recombinant Human Thrombin, Product Types and Applications
Table 14. Global Key Manufacturers of Topical Recombinant Human Thrombin, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Topical Recombinant Human Thrombin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Topical Recombinant Human Thrombin Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Topical Recombinant Human Thrombin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Topical Recombinant Human Thrombin Sales by Region (K Units), 2021–2026
Table 20. Global Topical Recombinant Human Thrombin Sales Market Share by Region (2021–2026)
Table 21. Global Topical Recombinant Human Thrombin Sales by Region (K Units), 2027–2032
Table 22. Global Topical Recombinant Human Thrombin Sales Market Share by Region (2027–2032)
Table 23. Global Topical Recombinant Human Thrombin Revenue by Region (US$ Million), 2021–2026
Table 24. Global Topical Recombinant Human Thrombin Revenue Market Share by Region (2021–2026)
Table 25. Global Topical Recombinant Human Thrombin Revenue by Region (US$ Million), 2027–2032
Table 26. Global Topical Recombinant Human Thrombin Revenue Market Share by Region (2027–2032)
Table 27. North America Topical Recombinant Human Thrombin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Topical Recombinant Human Thrombin Sales by Country (K Units), 2021–2026
Table 29. North America Topical Recombinant Human Thrombin Sales by Country (K Units), 2027–2032
Table 30. North America Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2021–2026
Table 31. North America Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Topical Recombinant Human Thrombin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Topical Recombinant Human Thrombin Sales by Country (K Units), 2021–2026
Table 34. Europe Topical Recombinant Human Thrombin Sales by Country (K Units), 2027–2032
Table 35. Europe Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Topical Recombinant Human Thrombin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Topical Recombinant Human Thrombin Sales by Region (K Units), 2021–2026
Table 39. Asia Pacific Topical Recombinant Human Thrombin Sales by Region (K Units), 2027–2032
Table 40. Asia Pacific Topical Recombinant Human Thrombin Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Topical Recombinant Human Thrombin Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Topical Recombinant Human Thrombin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Topical Recombinant Human Thrombin Sales by Country (K Units), 2021–2026
Table 44. Latin America Topical Recombinant Human Thrombin Sales by Country (K Units), 2027–2032
Table 45. Latin America Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Topical Recombinant Human Thrombin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Topical Recombinant Human Thrombin Sales by Country (K Units), 2021–2026
Table 49. Middle East and Africa Topical Recombinant Human Thrombin Sales by Country (K Units), 2027–2032
Table 50. Middle East and Africa Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2027–2032
Table 52. Global Topical Recombinant Human Thrombin Sales (K Units) by Capacity (2021–2026)
Table 53. Global Topical Recombinant Human Thrombin Sales (K Units) by Capacity (2027–2032)
Table 54. Global Topical Recombinant Human Thrombin Sales Market Share by Capacity (2021–2026)
Table 55. Global Topical Recombinant Human Thrombin Sales Market Share by Capacity (2027–2032)
Table 56. Global Topical Recombinant Human Thrombin Revenue (US$ Million) by Capacity (2021–2026)
Table 57. Global Topical Recombinant Human Thrombin Revenue (US$ Million) by Capacity (2027–2032)
Table 58. Global Topical Recombinant Human Thrombin Revenue Market Share by Capacity (2021–2026)
Table 59. Global Topical Recombinant Human Thrombin Revenue Market Share by Capacity (2027–2032)
Table 60. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Capacity (2021–2026)
Table 61. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Capacity (2027–2032)
Table 62. Global Topical Recombinant Human Thrombin Sales (K Units) by Application (2021–2026)
Table 63. Global Topical Recombinant Human Thrombin Sales (K Units) by Application (2027–2032)
Table 64. Global Topical Recombinant Human Thrombin Sales Market Share by Application (2021–2026)
Table 65. Global Topical Recombinant Human Thrombin Sales Market Share by Application (2027–2032)
Table 66. Global Topical Recombinant Human Thrombin Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Topical Recombinant Human Thrombin Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Topical Recombinant Human Thrombin Revenue Market Share by Application (2021–2026)
Table 69. Global Topical Recombinant Human Thrombin Revenue Market Share by Application (2027–2032)
Table 70. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Application (2021–2026)
Table 71. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Application (2027–2032)
Table 72. Baxter Company Information
Table 73. Baxter Description and Business Overview
Table 74. Baxter Topical Recombinant Human Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Baxter Topical Recombinant Human Thrombin Product
Table 76. Baxter Recent Developments/Updates
Table 77. Suzhou Zelgen Biopharmaceuticals Company Information
Table 78. Suzhou Zelgen Biopharmaceuticals Description and Business Overview
Table 79. Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Product
Table 81. Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Topical Recombinant Human Thrombin Distributors List
Table 85. Topical Recombinant Human Thrombin Customers List
Table 86. Topical Recombinant Human Thrombin Market Trends
Table 87. Topical Recombinant Human Thrombin Market Drivers
Table 88. Topical Recombinant Human Thrombin Market Challenges
Table 89. Topical Recombinant Human Thrombin Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Authors List of This Report
List of Figures
Figure 1. Product Picture of Topical Recombinant Human Thrombin
Figure 2. Global Topical Recombinant Human Thrombin Market Value by Capacity (US$ Million), 2021–2032
Figure 3. Global Topical Recombinant Human Thrombin Market Share by Capacity: 2025 & 2032
Figure 4. 2000/Bottle Product Picture
Figure 5. 5000/Bottle Product Picture
Figure 6. Others Product Picture
Figure 7. Global Topical Recombinant Human Thrombin Market Value by Solvent (US$ Million), 2021–2032
Figure 8. Global Topical Recombinant Human Thrombin Market Share by Solvent: 2025 vs 2032
Figure 9. Lyophilized Powder Product Picture
Figure 10. Ready to Use Solution Product Picture
Figure 11. Global Topical Recombinant Human Thrombin Market Value by Use (US$ Million), 2021–2032
Figure 12. Global Topical Recombinant Human Thrombin Market Share by Use: 2025 vs 2032
Figure 13. Direct External Use Product Picture
Figure 14. Carrier Composite External Use Product Picture
Figure 15. Global Topical Recombinant Human Thrombin Market Value by Application (US$ Million), 2021–2032
Figure 16. Global Topical Recombinant Human Thrombin Market Share by Application: 2025 & 2032
Figure 17. Hospital
Figure 18. Clinic
Figure 19. Global Topical Recombinant Human Thrombin Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Topical Recombinant Human Thrombin Market Size (US$ Million), 2021–2032
Figure 21. Global Topical Recombinant Human Thrombin Sales (K Units), 2021–2032
Figure 22. Global Topical Recombinant Human Thrombin Average Price (US$/Unit), 2021–2032
Figure 23. Topical Recombinant Human Thrombin Report Years Considered
Figure 24. Topical Recombinant Human Thrombin Sales Share by Manufacturers in 2025
Figure 25. Global Topical Recombinant Human Thrombin Revenue Share by Manufacturers in 2025
Figure 26. Top 5 and Top 10 Global Topical Recombinant Human Thrombin Players: Market Share by Revenue in Topical Recombinant Human Thrombin in 2025
Figure 27. Topical Recombinant Human Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 28. Global Topical Recombinant Human Thrombin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 29. North America Topical Recombinant Human Thrombin Sales Market Share by Country (2021–2032)
Figure 30. North America Topical Recombinant Human Thrombin Revenue Market Share by Country (2021–2032)
Figure 31. United States Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Canada Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Europe Topical Recombinant Human Thrombin Sales Market Share by Country (2021–2032)
Figure 34. Europe Topical Recombinant Human Thrombin Revenue Market Share by Country (2021–2032)
Figure 35. Germany Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. France Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. U.K. Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Italy Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Russia Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Asia Pacific Topical Recombinant Human Thrombin Sales Market Share by Region (2021–2032)
Figure 41. Asia Pacific Topical Recombinant Human Thrombin Revenue Market Share by Region (2021–2032)
Figure 42. China Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Japan Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. South Korea Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. India Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Australia Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. China Taiwan Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Indonesia Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Thailand Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Malaysia Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Latin America Topical Recombinant Human Thrombin Sales Market Share by Country (2021–2032)
Figure 52. Latin America Topical Recombinant Human Thrombin Revenue Market Share by Country (2021–2032)
Figure 53. Mexico Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Brazil Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Argentina Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Middle East and Africa Topical Recombinant Human Thrombin Sales Market Share by Country (2021–2032)
Figure 57. Middle East and Africa Topical Recombinant Human Thrombin Revenue Market Share by Country (2021–2032)
Figure 58. Turkey Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Saudi Arabia Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. UAE Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Global Sales Market Share of Topical Recombinant Human Thrombin by Capacity (2021–2032)
Figure 62. Global Revenue Market Share of Topical Recombinant Human Thrombin by Capacity (2021–2032)
Figure 63. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Capacity (2021–2032)
Figure 64. Global Sales Market Share of Topical Recombinant Human Thrombin by Application (2021–2032)
Figure 65. Global Revenue Market Share of Topical Recombinant Human Thrombin by Application (2021–2032)
Figure 66. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Application (2021–2032)
Figure 67. Topical Recombinant Human Thrombin Value Chain
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global Topical Recombinant Human Thrombin Market Value by Capacity (US$ Million), 2025 vs 2032
Table 2. Global Topical Recombinant Human Thrombin Market Value by Solvent (US$ Million), 2025 vs 2032
Table 3. Global Topical Recombinant Human Thrombin Market Value by Use (US$ Million), 2025 vs 2032
Table 4. Global Topical Recombinant Human Thrombin Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Topical Recombinant Human Thrombin Market Competitive Situation by Manufacturers in 2025
Table 6. Global Topical Recombinant Human Thrombin Sales (K Units) of Key Manufacturers (2021–2026)
Table 7. Global Topical Recombinant Human Thrombin Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Topical Recombinant Human Thrombin Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Topical Recombinant Human Thrombin Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Topical Recombinant Human Thrombin Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Topical Recombinant Human Thrombin, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Topical Recombinant Human Thrombin, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Topical Recombinant Human Thrombin, Product Types and Applications
Table 14. Global Key Manufacturers of Topical Recombinant Human Thrombin, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Topical Recombinant Human Thrombin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Topical Recombinant Human Thrombin Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Topical Recombinant Human Thrombin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Topical Recombinant Human Thrombin Sales by Region (K Units), 2021–2026
Table 20. Global Topical Recombinant Human Thrombin Sales Market Share by Region (2021–2026)
Table 21. Global Topical Recombinant Human Thrombin Sales by Region (K Units), 2027–2032
Table 22. Global Topical Recombinant Human Thrombin Sales Market Share by Region (2027–2032)
Table 23. Global Topical Recombinant Human Thrombin Revenue by Region (US$ Million), 2021–2026
Table 24. Global Topical Recombinant Human Thrombin Revenue Market Share by Region (2021–2026)
Table 25. Global Topical Recombinant Human Thrombin Revenue by Region (US$ Million), 2027–2032
Table 26. Global Topical Recombinant Human Thrombin Revenue Market Share by Region (2027–2032)
Table 27. North America Topical Recombinant Human Thrombin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Topical Recombinant Human Thrombin Sales by Country (K Units), 2021–2026
Table 29. North America Topical Recombinant Human Thrombin Sales by Country (K Units), 2027–2032
Table 30. North America Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2021–2026
Table 31. North America Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Topical Recombinant Human Thrombin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Topical Recombinant Human Thrombin Sales by Country (K Units), 2021–2026
Table 34. Europe Topical Recombinant Human Thrombin Sales by Country (K Units), 2027–2032
Table 35. Europe Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Topical Recombinant Human Thrombin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Topical Recombinant Human Thrombin Sales by Region (K Units), 2021–2026
Table 39. Asia Pacific Topical Recombinant Human Thrombin Sales by Region (K Units), 2027–2032
Table 40. Asia Pacific Topical Recombinant Human Thrombin Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Topical Recombinant Human Thrombin Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Topical Recombinant Human Thrombin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Topical Recombinant Human Thrombin Sales by Country (K Units), 2021–2026
Table 44. Latin America Topical Recombinant Human Thrombin Sales by Country (K Units), 2027–2032
Table 45. Latin America Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Topical Recombinant Human Thrombin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Topical Recombinant Human Thrombin Sales by Country (K Units), 2021–2026
Table 49. Middle East and Africa Topical Recombinant Human Thrombin Sales by Country (K Units), 2027–2032
Table 50. Middle East and Africa Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Topical Recombinant Human Thrombin Revenue by Country (US$ Million), 2027–2032
Table 52. Global Topical Recombinant Human Thrombin Sales (K Units) by Capacity (2021–2026)
Table 53. Global Topical Recombinant Human Thrombin Sales (K Units) by Capacity (2027–2032)
Table 54. Global Topical Recombinant Human Thrombin Sales Market Share by Capacity (2021–2026)
Table 55. Global Topical Recombinant Human Thrombin Sales Market Share by Capacity (2027–2032)
Table 56. Global Topical Recombinant Human Thrombin Revenue (US$ Million) by Capacity (2021–2026)
Table 57. Global Topical Recombinant Human Thrombin Revenue (US$ Million) by Capacity (2027–2032)
Table 58. Global Topical Recombinant Human Thrombin Revenue Market Share by Capacity (2021–2026)
Table 59. Global Topical Recombinant Human Thrombin Revenue Market Share by Capacity (2027–2032)
Table 60. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Capacity (2021–2026)
Table 61. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Capacity (2027–2032)
Table 62. Global Topical Recombinant Human Thrombin Sales (K Units) by Application (2021–2026)
Table 63. Global Topical Recombinant Human Thrombin Sales (K Units) by Application (2027–2032)
Table 64. Global Topical Recombinant Human Thrombin Sales Market Share by Application (2021–2026)
Table 65. Global Topical Recombinant Human Thrombin Sales Market Share by Application (2027–2032)
Table 66. Global Topical Recombinant Human Thrombin Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Topical Recombinant Human Thrombin Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Topical Recombinant Human Thrombin Revenue Market Share by Application (2021–2026)
Table 69. Global Topical Recombinant Human Thrombin Revenue Market Share by Application (2027–2032)
Table 70. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Application (2021–2026)
Table 71. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Application (2027–2032)
Table 72. Baxter Company Information
Table 73. Baxter Description and Business Overview
Table 74. Baxter Topical Recombinant Human Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Baxter Topical Recombinant Human Thrombin Product
Table 76. Baxter Recent Developments/Updates
Table 77. Suzhou Zelgen Biopharmaceuticals Company Information
Table 78. Suzhou Zelgen Biopharmaceuticals Description and Business Overview
Table 79. Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Product
Table 81. Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Topical Recombinant Human Thrombin Distributors List
Table 85. Topical Recombinant Human Thrombin Customers List
Table 86. Topical Recombinant Human Thrombin Market Trends
Table 87. Topical Recombinant Human Thrombin Market Drivers
Table 88. Topical Recombinant Human Thrombin Market Challenges
Table 89. Topical Recombinant Human Thrombin Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Authors List of This Report
List of Figures
Figure 1. Product Picture of Topical Recombinant Human Thrombin
Figure 2. Global Topical Recombinant Human Thrombin Market Value by Capacity (US$ Million), 2021–2032
Figure 3. Global Topical Recombinant Human Thrombin Market Share by Capacity: 2025 & 2032
Figure 4. 2000/Bottle Product Picture
Figure 5. 5000/Bottle Product Picture
Figure 6. Others Product Picture
Figure 7. Global Topical Recombinant Human Thrombin Market Value by Solvent (US$ Million), 2021–2032
Figure 8. Global Topical Recombinant Human Thrombin Market Share by Solvent: 2025 vs 2032
Figure 9. Lyophilized Powder Product Picture
Figure 10. Ready to Use Solution Product Picture
Figure 11. Global Topical Recombinant Human Thrombin Market Value by Use (US$ Million), 2021–2032
Figure 12. Global Topical Recombinant Human Thrombin Market Share by Use: 2025 vs 2032
Figure 13. Direct External Use Product Picture
Figure 14. Carrier Composite External Use Product Picture
Figure 15. Global Topical Recombinant Human Thrombin Market Value by Application (US$ Million), 2021–2032
Figure 16. Global Topical Recombinant Human Thrombin Market Share by Application: 2025 & 2032
Figure 17. Hospital
Figure 18. Clinic
Figure 19. Global Topical Recombinant Human Thrombin Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Topical Recombinant Human Thrombin Market Size (US$ Million), 2021–2032
Figure 21. Global Topical Recombinant Human Thrombin Sales (K Units), 2021–2032
Figure 22. Global Topical Recombinant Human Thrombin Average Price (US$/Unit), 2021–2032
Figure 23. Topical Recombinant Human Thrombin Report Years Considered
Figure 24. Topical Recombinant Human Thrombin Sales Share by Manufacturers in 2025
Figure 25. Global Topical Recombinant Human Thrombin Revenue Share by Manufacturers in 2025
Figure 26. Top 5 and Top 10 Global Topical Recombinant Human Thrombin Players: Market Share by Revenue in Topical Recombinant Human Thrombin in 2025
Figure 27. Topical Recombinant Human Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 28. Global Topical Recombinant Human Thrombin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 29. North America Topical Recombinant Human Thrombin Sales Market Share by Country (2021–2032)
Figure 30. North America Topical Recombinant Human Thrombin Revenue Market Share by Country (2021–2032)
Figure 31. United States Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Canada Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Europe Topical Recombinant Human Thrombin Sales Market Share by Country (2021–2032)
Figure 34. Europe Topical Recombinant Human Thrombin Revenue Market Share by Country (2021–2032)
Figure 35. Germany Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. France Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. U.K. Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Italy Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Russia Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Asia Pacific Topical Recombinant Human Thrombin Sales Market Share by Region (2021–2032)
Figure 41. Asia Pacific Topical Recombinant Human Thrombin Revenue Market Share by Region (2021–2032)
Figure 42. China Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Japan Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. South Korea Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. India Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Australia Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. China Taiwan Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Indonesia Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Thailand Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Malaysia Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Latin America Topical Recombinant Human Thrombin Sales Market Share by Country (2021–2032)
Figure 52. Latin America Topical Recombinant Human Thrombin Revenue Market Share by Country (2021–2032)
Figure 53. Mexico Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Brazil Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Argentina Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Middle East and Africa Topical Recombinant Human Thrombin Sales Market Share by Country (2021–2032)
Figure 57. Middle East and Africa Topical Recombinant Human Thrombin Revenue Market Share by Country (2021–2032)
Figure 58. Turkey Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Saudi Arabia Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. UAE Topical Recombinant Human Thrombin Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Global Sales Market Share of Topical Recombinant Human Thrombin by Capacity (2021–2032)
Figure 62. Global Revenue Market Share of Topical Recombinant Human Thrombin by Capacity (2021–2032)
Figure 63. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Capacity (2021–2032)
Figure 64. Global Sales Market Share of Topical Recombinant Human Thrombin by Application (2021–2032)
Figure 65. Global Revenue Market Share of Topical Recombinant Human Thrombin by Application (2021–2032)
Figure 66. Global Topical Recombinant Human Thrombin Price (US$/Unit) by Application (2021–2032)
Figure 67. Topical Recombinant Human Thrombin Value Chain
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232